A PCR test detects the actual genetic material of the virus and involves a step that amplifies the presence of any material ...

The agency might dissuade patients from participating in a crucial part of our research-and-development system.

New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments—such as monoclonal antibodies—sooner.

The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...

Augurex’s Spinestat diagnostic test earned the FDA’s breakthrough device designation. Spinestate is a 14-3-3eta autoantibody multiplex immunoassay test for diagnosing axial spondyloarthritis, ...

A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.

Dear Savvy Senior, With a longtime vaccine critic leading the nation’s health departments, can you give me updated ...

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

A new eye drop, Vizz, was recently FDA approved and is helping people regain near vision without glasses. Originally used for glaucoma, the drops are now repurposed for presbyopia (age-related ...

A wave of social media posts has misleadingly interpreted a recent statement made by the European Commission, framing it as a bombshell admission that COVID-19 vaccines were passed without proper ...

As excitement around animal testing alternatives reaches a fever pitch, Charles River Laboratories is making a move to strengthen its development of new approach methodologies (NAMs) that can ...